Bram Rochwerg to Coronavirus Infections
This is a "connection" page, showing publications Bram Rochwerg has written about Coronavirus Infections.
Connection Strength
0.182
-
Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19. Ann Intern Med. 2020 11 17; 173(10):860.
Score: 0.029
-
Update Alert: Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19. Ann Intern Med. 2020 09 15; 173(6):W122.
Score: 0.028
-
Remdesivir for severe covid-19: a clinical practice guideline. BMJ. 2020 07 30; 370:m2924.
Score: 0.028
-
A case of possible Fournier's gangrene associated with proning in COVID-19 ARDS. Can J Anaesth. 2020 11; 67(11):1697-1698.
Score: 0.028
-
CMAJ. 2020 10 26; 192(43):E1323-E1333.
Score: 0.007
-
A national cross-sectional survey of public perceptions of the COVID-19 pandemic: Self-reported beliefs, knowledge, and behaviors. PLoS One. 2020; 15(10):e0241259.
Score: 0.007
-
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. JAMA. 2020 10 06; 324(13):1317-1329.
Score: 0.007
-
A living WHO guideline on drugs for covid-19. BMJ. 2020 09 04; 370:m3379.
Score: 0.007
-
Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ. 2020 07 30; 370:m2980.
Score: 0.007
-
High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission. Can J Anaesth. 2020 09; 67(9):1217-1248.
Score: 0.007
-
Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19: A Living Systematic Review of Multiple Streams of Evidence. Ann Intern Med. 2020 08 04; 173(3):204-216.
Score: 0.007
-
Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis. CMAJ. 2020 07 06; 192(27):E756-E767.
Score: 0.007
-
Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline. CMAJ. 2020 05 19; 192(20):E536-E545.
Score: 0.007
-
Ensuring nondiscrimination in pandemic prioritization decisions. CMAJ. 2020 04 14; 192(15):E421.
Score: 0.007